Cognizant Technology Solutions Corporation (NASDAQ:CTSH) stock has reached a 52-week high, touching $82.48 in a notable uptick that reflects investor confidence in the company's growth trajectory.

Thursday announced that it has expanded its long-standing collaboration with Gilead Sciences (GILD) to enhance cost ...

Corporation (NASDAQ: CTSH) has announced the expansion of its partnership with biopharmaceutical company Gilead Sciences (NASDAQ: NASDAQ:GILD), aiming to enhance Gilead's customer service, employee ...

Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

Cognizant (CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (GILD) that aims to ...

Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as ...

The testimony of Srimanikandan Ramamoorthy, dubbed the essential witness by the US Department of Justice, is critical, ...

Get the latest updates on the company's financial performance, strategic acquisitions, and market shifts. Explore detailed ...

Alongside the campus development, TCS is also scouting for office space at InfoPark in Kochi to meet its immediate need for ...